D
Absci Corporation ABSI
$2.80 $0.145.26% NASDAQ
Recommendation
Prev Close
$2.66
Volume
3,293,336
Avg Vol (90D)
4,711,453
Market Cap
$338.76M
Dividend & Yield
--
52-Week Range
$2.01 - $6.33
P/E (TTM)
--
EPS (TTM)
-$0.9337
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Which Healthcare Stock Is the Best Buy Right Now?
3/31/2025 - MarketBeat
Absci (ABSI) to Release Earnings on Tuesday
5/8/2025 - MarketBeat
Absci (ABSI, $3.03) entered Downtrend as Momentum indicator drops below 0 level on Apr 29, 2025
4/30/2025 - Tickeron - Technical Analysis
Jump Financial LLC Acquires New Shares in Absci Co. (NASDAQ:ABSI)
4/28/2025 - MarketBeat
Eversept Partners LP Trims Position in Absci Co. (NASDAQ:ABSI)
4/22/2025 - Ticker Report
KeyCorp Increases Absci (NASDAQ:ABSI) Price Target to $9.00
4/18/2025 - MarketBeat
KeyBanc Increases Price Target for Absci (ABSI) to $9 Amid Healthcare Sector Trends ABSI ...
4/16/2025 - GuruFocus
Absci (ABSI, $3.12) Aroon Indicator entered a Downtrend on April 15, 2025.
4/16/2025 - Tickeron - Stocks
Absci price target raised by $4 at KeyBanc, here's why
4/16/2025 - The Fly
Kennedy Capital Management LLC Has $270,000 Stock Position in Absci Co. (NASDAQ:ABSI)
4/16/2025 - Ticker Report
KeyBanc Reaffirms Their Buy Rating on AbSci (ABSI)
4/16/2025 - TipRanks Financial Blog
Absci (ABSI, $3.09) Aroon Indicator entered a Downtrend on April 14, 2025.
4/15/2025 - Tickeron - Stocks
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May ...
4/14/2025 - GuruFocus
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May ...
4/14/2025 - GuruFocus
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025
4/14/2025 - Globe Newswire
Absci: FDA Announcement Provides Only A Modest Tailwind
4/14/2025 - SeekingAlpha
Absci (ABSI, $3.02) Aroon Indicator entered a Downtrend on April 11, 2025.
4/12/2025 - Tickeron - Technical Analysis
Absci (ABSI, $3.02) entered Uptrend as Momentum indicator ascends above 0 level on Apr 11, 2025
4/12/2025 - Tickeron - Technical Analysis
Commit To Buy Absci At $2, Earn 36.7% Annualized Using Options
4/11/2025 - Stock Options Channel
Futures Flat, Gold Soars, Dollar Crashes After China Hikes US Tariffs To 125%
4/11/2025 - Zero Hedge
Absci (NASDAQ:ABSI) Given "Buy" Rating at Needham & Company LLC
4/11/2025 - MarketBeat
Absci Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
4/9/2025 - Benzinga
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market
4/3/2025 - Seeking Alpha - Long Ideas
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market
4/3/2025 - SeekingAlpha
Absci Corporation announces resale of 5.71M shares by selling stockholders
4/1/2025 - Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
$4.53M
EBITDA (TTM)
-$94.10M
EBIT (TTM)
-$107.49M
Net Income (TTM)
-$103.11M
Balance Sheet
Total Assets (Q)
$213.61M
Total Debt (Q)
$10.11M
Total Liabilities (Q)
$34.48M
Book Value Per Share (Q)
$1.55
Cash Flow
Cash from Operations (TTM)
-$72.40M
Cash from Investing (TTM)
-$41.58M
Cash from Financing (TTM)
$82.53M
Net Change in Cash (TTM)
-$31.45M
Filings
Filing Date
Tuesday, March 18, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
2.95
7-Day Total Return
-7.59%
30-Day Total Return
-3.45%
60-Day Total Return
-42.97%
90-Day Total Return
-6.04%
Year to Date Total Return
3.32%
1-Year Total Return
-43.32%
2-Year Total Return
97.18%
3-Year Total Return
-34.73%
5-Year Total Return
--
52-week Low
Apr 04, 2025 - $2.01
52-week High
Feb 18, 2025 - $6.33
Valuation
Market Cap
$338.76M - Small Cap
Enterprise Value
$236.44M
Price/Sales (TTM)
67.51
Price/Book (Q)
1.71
Dividends and Shares
Shares Outstanding
114.93M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.absci.com
Phone Number
360 949 1041
Address
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
Country
United States
Year Founded
2011
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design... more
NASDAQ 05/08/2025 4:00PM Eastern Quotes delayed